C4IP is a bipartisan coalition dedicated to promoting strong and effective IP rights that drive innovation, boost economic competitiveness, and improve lives.

Joined August 2022
📣 C4IP today announced that Coke Morgan Stewart, a nationally recognized leader in IP law and policy and former @USPTO deputy director, has joined the organization as president and CEO. Her appointment marks a new chapter for C4IP as it expands its reach and advocacy for strong and secure IP rights. Read our full statement: c4ip.org/council-for-innovat…
1
2
251
"[I]f Americans want future garage-shop inventors and independent creators to have a fighting chance, we need to preserve our intellectual property system -- our great equalizer." - @StewartCoke, C4IP president and CEO, in @FortuneMagazine Read her full op-ed: fortune.com/2026/10/27/ai-in…
8
🚨 New C4IP Statement: The Council for Innovation Promotion today raised concerns about potential unintended consequences for American biotechnology innovation under the U.S. Treasury Department's proposed efforts to protect national security through restrictions on certain outbound investments. Read more here: c4ip.org/c4ip-urges-protecti…
16
📅 On Nov. 6, at @uiclaw's 70th Annual Intellectual Property, Information & Privacy Law Conference, C4IP President and CEO Coke Morgan Stewart will join other IP experts to discuss the latest developments in the intellectual property field. Learn more and register: law.uic.edu/events/70th-annu…
13
"The Gila monster did not give us GLP-1s. Scientists -- and a patent system that encourages companies to continually invest in new research -- did." Read more about GLP-1s and the patent system in @FortuneMagazine: fortune.com/2026/10/10/glp1-…
23
Activists have propagated false narratives about how patents stifle competition in the drug industry and keep generic drugs from coming to market But so-called "patent thickets" and "product hopping" are commonly cited myths that do not stand up to scrutiny. Learn more about patent myths: c4ip.org/resources-that-help…
.@RSI article underscores the importance of market-based solutions to promote greater generic and biosimilar competition. Learn more about how competition from more affordable alternatives is critical to lowering costs:

24
Nearly every technology, life-saving invention, and creative work we rely on daily was made possible by strong intellectual property protections. On @CenterforIP's podcast, Corey Salsberg explores how IP literacy can build awareness of IP's everyday impact: buzzsprout.com/1537696/episo…
17
American innovation owes much to the researchers, inventors, and tech transfer professionals who help turn federally supported discoveries into useful products. Celebrate their contributions. Submit a nomination for the Bayh-Dole Coalition's 2027 American Innovator Award 👇
Don't forget: Nominations are open for the 2027 American Innovator Award! 🏆 Know someone helping turn groundbreaking research into real-world innovation? Learn who we're looking to recognize and how to submit a nomination on our website: buff.ly/1ciYxYj
1
1
35
The United States' multibillion-dollar intellectual property trade surplus underscores its immense value as a strategic asset. David Kappos, C4IP co-chair and former USPTO director, explains how strong IP protections promote American innovation and drive our country's economic growth.
1
1
45
Supporters of the ETHIC Act frame it as a way to reduce drug prices by preventing pharmaceutical companies from constructing so-called "patent thickets." But those supporters are misunderstanding, or misconstruing, how the patent system works. Get the facts on the ETHIC Act: c4ip.org/wp-content/uploads/…
1
25
"Chinese courts have recently asserted the authority to set worldwide licensing terms for SEPs, threatening market-based licensing and the value of American inventions." Read more on this and other IP concerns in our public comment to @USTradeRep: c4ip.org/wp-content/uploads/…
26
Far from being a tactic to extend market exclusivity through duplicative patents, terminal disclaimers prevent duplicative patenting. Yet some critics repeatedly argue that drug patents linked by terminal disclaimers are duplicative and unnecessary. Our blog post sets the record straight: c4ip.org/fact-check-correcti…
15
Charles Hull transformed manufacturing, medicine, and design through his invention of stereolithography -- better known as 3D printing. During IP Month, we're recognizing innovators like Hull and the IP rights that help turn groundbreaking ideas into real-world technologies. Learn more about Hull's story: c4ip.org/inventor-spotlight-…
17
"As artificial intelligence continues to transform how content is created and distributed, policymakers must ensure that individuals are not left vulnerable to exploitation and deception." - C4IP Executive Director Frank Cullen See how the NO FAKES Act would help: c4ip.org/council-for-innovat…
24
Check out C4IP Chief Policy Officer Jamie Simpson's new piece in @IPWatchdog on why Congress should reject the Medication Affordability and Patent Integrity Act: "Inventions that often take more than a decade and enormous investment to reach patients are too valuable to be forfeited over a paperwork error." Continue reading ⬇️ ipwatchdog.com/2026/10/21/do…
1
36
"...the incentives created by the IP system are foundational to the U.S. economy and, frankly, to economic freedom for individuals in the U.S." - C4IP President and CEO Coke Morgan Stewart, speaking at @AUTM on the Road in Washington, D.C. For more info about the event ⬇️ autm.net/events/autm-on-the-…
32
Intellectual Property Month offers an opportunity to celebrate the inventions that have shaped American life and the IP rights that enabled their success. Our latest blog post highlights four patents that made history, from the nation's first patent to the sports bra. Read it: c4ip.org/celebrating-ip-mont…
1
32